AI digital twins help manage diabetes and obesity

Silicon Valley startup Twin Health uses AI and wearable sensors as an alternative to expensive GLP-1 drugs for weight management. Retired firefighter Rodney Buckley lost 100 pounds in under a year through the program. His experience highlights a shift toward personalized health tech for chronic conditions.

As demand grows for cost-effective options beyond GLP-1 medications, companies like Twin Health are turning to artificial intelligence to support better health decisions. The startup employs digital twins—virtual models of individuals—and wearable sensors to guide users in managing diabetes and obesity.

Rodney Buckley, a 55-year-old retired firefighter and current village mayor of Third Lake, Illinois, joined the program last March when it was offered through his wife's employer. At that time, he weighed 376 pounds and had a history of unsuccessful dieting attempts, where he would lose weight only to regain it later. Without relying on GLP-1 drugs, Buckley achieved a 100-pound weight loss in less than a year using Twin Health's approach.

This method focuses on data-driven insights from wearables to encourage healthier choices, appealing to both patients and employers seeking sustainable solutions. The program's integration into workplace benefits underscores a broader trend in health care toward tech-enabled personalization for metabolic conditions.

Awọn iroyin ti o ni ibatan

Athlete using sweat-sensing AI wearable for real-time, needle-free health monitoring of biomarkers like glucose and stress hormones in a lab setting.
Àwòrán tí AI ṣe

Study examines sweat-sensing AI wearables for early, needle-free health monitoring

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

Researchers at the University of Technology Sydney are exploring how sweat-sensing wearables, combined with artificial intelligence, could enable real-time, non-invasive tracking of health biomarkers. Their work suggests that sweat-based monitoring might one day help flag risks for conditions such as diabetes and other chronic diseases before symptoms appear, offering a painless complement to some blood tests for tracking hormones, medications, and stress-related biomarkers.

Health care company Abbott has introduced Libre Assist, a new AI-powered tool within its Libre app, designed to help people with diabetes assess the potential impact of their meals on glucose levels before eating. Users can simply photograph or describe their food to receive predictions and tips. The feature, unveiled at CES 2026, integrates with Abbott's FreeStyle Libre continuous glucose monitors for post-meal insights.

Ti AI ṣe iroyin

Apple is rethinking its plans for an AI-powered health coach, opting to release features individually rather than as a single package. The project, internally known as Mulberry or Health+, faces changes amid leadership shifts and competitive pressures. Individual tools, including videos and data recommendations, may still launch soon.

Two Chinese patients with high-level paralysis have successfully used brain-machine interface (BMI) technology to control a power wheelchair, direct a robotic dog to retrieve deliveries, and operate a robotic arm to grasp a cup and drink water using only their thoughts. The achievements were announced on Wednesday at a media briefing by the Center for Excellence in Brain Science and Intelligence Technology of the Chinese Academy of Sciences in Shanghai. This marks a major advancement toward practical clinical applications of BMI.

Ti AI ṣe iroyin

In 2025, Indians went beyond chasing weight loss or wellness hacks to renegotiate their relationships with food, medicine and their own bodies.

Utah has introduced a pilot program allowing artificial intelligence to refill prescriptions without human oversight, marking a significant step in medical innovation. The initiative, partnered with telehealth startup Doctronic, targets common medications for chronic conditions amid concerns over safety and regulation. Public advocates have labeled the program dangerous due to its potential risks.

Ti AI ṣe iroyin

The US Department of Health and Human Services is creating a generative AI tool to analyze vaccine injury claims. The tool aims to identify patterns in a national monitoring database and generate hypotheses on vaccine side effects. Experts express concerns about its potential use under Robert F. Kennedy Jr.'s leadership.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ